Thank you for visiting our stand at ESHRE 2019, it was great to see you. For those who didn’t attend, and those who did, here’s a recap of all the exciting things that took place in Vienna.


How to optimize treatment for poor prognosis patients was the focus of our sponsored symposium on Tuesday 25 June, which highlighted the need to adopt a personalized approach for patients suffering recurrent miscarriages and implantation failures.

Our speakers shared their experiences of using various treatment solutions that have improved outcomes for this patient subsection. These included the adoption of hyaluronan binding sperm selection products, the use of GM-CSF enriched culture media, and genomic testing including endometrial receptivity testing and PGT.

View the presentations below:

IppokratisSarrisOptimizing treatment of Poor Prognosis Patients
Ippokratis Sarris MD

Optimizing sperm selection for ART using HBA and PICSI
Lucy Richardson PhD

Reflections and results following the use of  GM-CSF enriched culture media at Care Fertility
Sue Montgomery PhD

Improving ART prognosis with genomic testing: Endometrial receptivity testing and PGT
Tony Gordon

One shoe does not fit all

In the fairytale ballroom location of our ESHRE Customer Party, guest speaker Sarah Norcross, Commissioning Editor of BioNews and Director of the Progress Educational Trust (PET), skillfully compared the challenges faced by ART patients (in finding the right treatment route) with Cinderella finding Prince Charming.

Cinderella’s Fairy Godmother thought ‘out of the box’, turning a pumpkin into a carriage to get her to the ball. With the correct solutions at hand, embryologists could also help dreams come true for patients facing particular difficulties when trying to have a family.


New improved technology platform

We announced the upcoming launch of our updated PGT technology platform PGTai℠ 2.0.

Since the PGTai technology platform was introduced last November, we have seen an increase in the number of euploids we report, and an increase in the number of patients across all age ranges that have at least one euploid embryo reported.* This advancement in accuracy is of huge benefit to all patients, particularly so for poor prognosis patients over the age of 35, or those with a history of miscarriage.

More euploids, more confidence, more transfers with PGTai 2.0

By introducing single nucleotide polymorphism (SNP) analysis and paired-end sequencing, the improved PGTai 2.0 platform provides even more robust PGT-A interpretation. Most importantly for clinicians and patients, the platform will deliver added accuracy, allowing embryos to be prioritized for transfer with more confidence.

*CooperSurgical internal data: prior (subjective) methodology, Jan 1, 2018 through Nov 1, 2018 vs PGTai technology platform, Nov 2, 2018 through May 31, 2019


Our ESHRE 2019 Speaker Schedule was packed as ever, featuring a fantastic line-up of speakers sharing their knowledge and insights within their respective fields of IVF and genetics.

Both Stephen Troup PhD, Consultant Reproductive Scientist and Steve Levett PhD, Director of Clinical Application CooperSurgical picked up the point that, despite all the advances in technology, it is important to continue to review how you address the basics of embryology, ie culture media pH monitoring.

They expand their recommendations in the latest ART Scientific “IVF Culture Media – Is It Time To Go Back To Basics?” and associated blog post “Embryologists: Why you Should Test your pH” which were snapped up by those attending ESHRE.

If you missed out collecting copies, you can access this edition of ART Scientific here or the pH monitoring article here.

For those who didn’t catch the talk given by David Chrimes PhD on ERPeak℠ endometrial receptivity test: enabling precision embryo transfer, download the white paper today.


We were also able to share the vast knowledge of our own team during the very popular on-stand 1-2-1 Biopsy and Lab Audit sessions.

During Lab Audit introduction sessions, run by David Morroll PhD, Director of Embryology, CooperSurgical, Lab Directors were able to identify which type of service meet their needs and ambitions to optimize outcomes. These include a general or trouble shooting audit. Having a fresh pair of trained independent eyes, provides a new perspective on lab processes and where improvements could be made.

Lodo Parmegiani PhD, Laboratory Director, GynePro Medical Center, once again held very popular demonstrations on sperm selection as well as how to improve vitrification efficiency. If you are interested in finding out more about more in-depth training sessions in these fields, click here for a list of relevant training course dates.

Thank You for attending ESHRE Vienna 2019